A. Goette
Cardiology and Cardiovascular Medicine · 2000–2020
A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 314 citations into it
Whom A. Goette trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Goette overall
Papers from A. Goette's perspective
Ordered by how strongly the researchers A. Goette trusts endorse each paper. Same corpus, a different order for every researcher.
- Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation (Circulation)
- The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. (Circulation Research)
- C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation (Circulation)
- Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. (Journal of the American Medical Association (JAMA))
- Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. (Journal of the American Medical Association (JAMA))
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. (New England Journal of Medicine)
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. (Journal of the American College of Cardiology)
- Inflammation in atrial fibrillation. (Journal of the American College of Cardiology)
- Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). (Journal of the American College of Cardiology)
Their papers
- Altered Expression of ADAMs (A D isintegrin A nd M etalloproteinase) in Fibrillating Human Atria (2002) — 106 citations
- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (2020) — 1,551 citations
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. (2018) — 1,738 citations
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016) — 719 citations
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. (2014) — 654 citations
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. (2012) — 3,028 citations
- Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. (2011) — 1,239 citations
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) — 3,695 citations
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) — 4,092 citations
- Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. (2000) — 598 citations